70% of India’s population lives in rural, village communities without reliable access to medical services including blood glucose testing,
Blood Glucose Numbers + Diagnostics= Database
Accessible health data is the single most important piece of information a doctor uses to make decisions in regards to a patient having or are at-risk of developing a chronic disease. Diabetics are recommended to test their blood sugar between 6-8 times a day, but researchers have indicated that as low as 6.5% of diabetic test more than once a month in India where self-management is rare. Sucre Blue collects this health data, and community health workers inputs into a database used for policymakers within India, as well as improving the relationship between doctors and their patients.
Pictured: The importance of blood glucose testing for diabetics and at-risk patients shown in Kannada and English.
Our villages are between 50-150 kms from Bangalore, and do not have access to a pharmacy, doctor, or hospital within 30 kms.
Door-to-door service + Convenience= Earlier Adoption
A significant number of the low-income populations do not have access to healthcare providers who possess trained expertise in diabetes management. The absence of the required technical knowledge can understandably result in disastrous medical outcomes. The products we distribute in rural communities are currently unavailable outside of Tier II cities, or cities which have a population of roughly one million people.
Pictured: An empty government hospital located in one of our villages served, a common challenge in many rural areas of India.
Up to 25% of a diabetic’s annual income can go to medical-related costs.
Lowering the Cost of Product + Life-Saving Service and Education= Happy Patients
Poor healthcare is one of the greatest causes of poverty. For an individual earning less than $2 a day, this presents significant challenges from taking time off work to taking out loans for medical care in places like India where over 70% of the population lives without insurance. The average up-front cost to monitoring is roughly 4000 rps, or $80, with additional 1000 rps ($20) cost for every 50 strip bottle purchased.
Patients are unable to purchase blood glucose strips individually, unlike many products in India, which results in higher upfront costs and increases the barriers to purchasing products designed to improve the overall management of those living with chronic diseases. Average diabetic monitoring by US standards is 5-7 times per diem, or roughly $1.75. We lower these costs significantly and hope to improve the dismal rates of blood glucose testing within India which has less than 6% of the population testing more than once per quarter.
Pictured: One of our first screenings where we diagnosed over 30% of the population having diabetes. Worldwide diabetes is at roughly 8% prevalence.
Continual Follow Up + Strong Referral Partners= Building Trust Organically
Rules of Halves in Action
Only half of the 366 million diabetics worldwide have been diagnosed. Only half of those receive professional care. Only half of those receive their treatment targets. And only half of those reach treatment targets without complications. But 21% more reach their targets with diabetic education. Our community health workers are trained to provide holistic education and awareness on a range of issues from diet and exercise, to reducing the social stigma these diseases carry in rural areas. Once our community health workers have identified a new patient, Sucre Blue will continue to follow up with the patient as well as maintain an open dialogue with our referral partners after the patient receives additional treatment.
Pictured: Example of referral system for newly diagnosed patients to receive ongoing and comprehensive treatment at Jnana Sanjeevini.
Prevent high-cost complications= Saving a Family from Financial Ruin of Losing a Job or Death
Low Cost Interventions= Longer, Happier Lives
In the developed world, the largest group of diabetics are aged 65 and above. However, in India, the largest group of diabetics fall in the range of 45-64 years (Mohan, 2004), with the Chennai Urban Population Study (CUPS) estimating that 25% of diabetics in India are in the age group 45-60. The economic implications of this difference are profound as these individuals are often in the most financially productive period of their lives. Compromised health at this stage often has an impact beyond just the individuals themselves and affects the prospects of the entire family unit. We believe our interventions combat poverty by allowing individuals to continue working, and avoid expensive complications that come from chronic diseases.
Pictured: Ratnamma, one of our first community health workers, holding her child. Both Ratnamma and her husband are diabetic.